InsiderTrades

Form 4 for MRK Merck & Co.

Accepted 2022-05-05 00:00:00 ET · period of report 2022-05-03 · accession 0001127602-22-013549 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-05-05 2022-05-04 MRK Oosthuizen Johannes Jacobus SVP, U.S. Market M - OptEx $87.10 +907 15.0K +6% +$79.0K
D 2022-05-05 2022-05-04 MRK Oosthuizen Johannes Jacobus SVP, U.S. Market F - Tax $87.10 -447 14.5K -3% -$38.9K
D 2022-05-05 2022-05-04 MRK Oosthuizen Johannes Jacobus SVP, U.S. Market M - OptEx $0.00 -907 1,819 -33% $0
D 2022-05-05 2022-05-03 MRK Oosthuizen Johannes Jacobus SVP, U.S. Market A - Grant $0.00 +21.4K 21.4K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-04 M A 907 $87.10 14,960.88 D — —
2 Common Common Stock 2022-05-04 F D 447 $87.10 14,513.88 D — — (F1) Holdings include shares acquired in dividend reinvestment transactions.
3 Derivative Restricted Stock Unit 2022-05-04 M D 907 $0.00 1,819 D — · 2022-05-04 to 2024-05-04 907 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024.
4 Derivative Stock Option (Right to Buy) 2022-05-03 A A 21,359 $0.00 21,359 D $87.10 · 2023-05-03 to 2032-05-02 21,359 Common Stock (F4) The option vests and becomes exercisable in equal installments on 5/3/2023, 5/3/2024 and 5/3/2025.